Publications by authors named "Jose Gustavo Romaldini"

Objective: The aim of this study was to assess the laboratory performance of periostin associated with a panel of biomarkers to identify the inflammatory phenotype of Brazilian asthma patients.

Methods: We evaluated 103 Brazilian individuals, including 37 asthmatics and 66 nonasthmatic controls. Both groups underwent analyses for serum periostin, eosinophil levels in the peripheral blood, the fraction of exhaled nitric oxide (FeNO), total serum IgE, urinary leukotriene E4, and serum cytokines.

View Article and Find Full Text PDF
Article Synopsis
  • - The treatment for Chronic Obstructive Pulmonary Disease (COPD) has improved with a variety of strategies, including behavioral changes, education, rehabilitation, and personalized medication plans tailored to each patient.
  • - Advances in pharmacological treatments are critical for COPD management, but the growing number of available drugs makes it harder to understand their specific indications and risks.
  • - A group of 24 specialists in Brazil created a visual guide to classify and treat COPD, addressing key clinical questions to help healthcare providers choose the best treatment options for individual patients.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Jose Gustavo Romaldini"

  • - Recent research by Jose Gustavo Romaldini has focused on identifying inflammatory biomarkers in asthma, specifically highlighting periostin as a significant biomarker for the inflammatory phenotype T2 in Brazilian asthma patients.
  • - His study involved a comparative analysis of serum periostin levels and other biomarkers between 37 asthmatic individuals and 66 non-asthmatic controls, revealing critical insights into the pathogenic mechanisms of asthma in the Brazilian population.
  • - Additionally, Romaldini has contributed to guidelines on the pharmacological treatment of Chronic Obstructive Pulmonary Disease (COPD), emphasizing personalized care and the importance of integrating various treatment modalities for optimal patient management.